News from us and our partners

Tags

Topics

0 results

News
18 August, 2026
HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer
News
11 August, 2026
Nitrase Therapeutics announces appointment of industry veterans to Board of Directors
News
11 August, 2026
Galvanize Therapeutics® announces first commercial procedures using New Aliya® EX System
News
6 August, 2026
Mediar Therapeutics enters collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases
News
5 August, 2026
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
News
28 July, 2026
HAYA Therapeutics receives FDA Fast Track Designation for HTX-001
News
22 July, 2026
Moon Surgical and KARL STORZ announce strategic commercial collaboration to advance scalable surgery
News
21 July, 2026
MaxCyte® announces multi-platform technology license partnership with Genentech® to advance cell therapy development
News
17 July, 2026
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
News
16 July, 2026
Mane expands partnership with Arzeda to accelerate commercialization of Vialeaf™ REB M
News
14 July, 2026
Elevara Medicines appoints biotech veteran as CEO
News
13 July, 2026
Sofinnova Partners appoints David Evans as Partner
News
13 July, 2026
Tenpoint Therapeutics announces United Kingdom submission of marketing authorization application for YUVEZZI™ treatment of Presbyopia in adults
News
8 July, 2026
Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders
News
8 July, 2026
Seven years: the journey behind Myricx's acquisition by Novartis
News
8 July, 2026
Abivax Announces Closing of $920 Million Public Offering

HotSpot Therapeutics appoints Niti Goel, M.D., as Chief Medical Officer

Nitrase Therapeutics announces appointment of industry veterans to Board of Directors

Galvanize Therapeutics® announces first commercial procedures using New Aliya® EX System

Mediar Therapeutics enters collaboration and option agreement with Ono Pharma to develop novel treatments for fibro-inflammatory diseases

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

HAYA Therapeutics receives FDA Fast Track Designation for HTX-001

Moon Surgical and KARL STORZ announce strategic commercial collaboration to advance scalable surgery

MaxCyte® announces multi-platform technology license partnership with Genentech® to advance cell therapy development

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline

Mane expands partnership with Arzeda to accelerate commercialization of Vialeaf™ REB M

Elevara Medicines appoints biotech veteran as CEO

Sofinnova Partners appoints David Evans as Partner

Tenpoint Therapeutics announces United Kingdom submission of marketing authorization application for YUVEZZI™ treatment of Presbyopia in adults

Inventiva Strengthens Board of Directors with Appointment of Three Distinguished Life Sciences Leaders

Seven years: the journey behind Myricx's acquisition by Novartis

Abivax Announces Closing of $920 Million Public Offering